<DOC>
	<DOCNO>NCT02102204</DOCNO>
	<brief_summary>This multicenter , single-arm , extension study characterize long-term safety tolerability AMG 416 treatment SHPT subject CKD hemodialysis .</brief_summary>
	<brief_title>To Assess Long-term Safety AMG 416 Treatment SHPT Subjects With CKD Hemodialysis</brief_title>
	<detailed_description>This multicenter , single-arm , extension study subject secondary hyperparathyroidism currently receive hemodialysis previously treat AMG 20120231 , 20120334 , 20120360 continue treat AMG 416 . The study assess long-term safety tolerability AMG 416 well measure intact parathyroid hormone ( iPTH ) , total serum albumin , correct calcium ( cCa ) , serum phosphorous ( P ) value subject course treatment .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Hyperparathyroidism , Secondary</mesh_term>
	<criteria>Subject provide informed consent prior initiation studyspecific activities/procedures Subject complete treatment Study 20120231 ( also know KAI4169008 ) Study 20120360 , participate Study 20120334 ( also know KAI416900501 ) Female subject : post menopausal ( post menopausal define menses previous 1 year age 50 year ) , surgically sterilize , medical condition prevents pregnancy , remain abstinent , willing use acceptable method effective contraception study 3 month last dose . Women childbearing potential ( WOCBP ) must negative serum pregnancy test within 2 week prior first dose AMG 416 current study Subject must receive hemodialysis 3 4 time weekly least 3 month Currently receive treatment another investigational device drug study ( one designate parent study ) Subject know sensitivity product component administer dose Subject prescribe cinacalcet primary nephrologist conclusion parent study start dose AMG 416 current study Subject receive dialysis prescription dialysate calcium concentration &lt; 2.25 mEq/L Subject pregnant nursing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>110 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Secondary Hyperparathyroidism ( SHPT ) , chrominc kidney disease ( CKD ) , hemodialysis</keyword>
</DOC>